|
2023-11-17 |
2023-11-15 |
V
Vente
|
Gobel David
Administrateur non-exécutif
|
19 607
-100.0%
1,62
31 750 USD
|
19 607
-100.0%
|
1,62
|
31 750 USD
|
|
|
2019-08-19 |
2019-08-16 |
V
Vente
|
Hughes Steven George
Chief Medical Officer
Dirigeant
|
22 230
-13.8%
0,29
6 431 USD
|
22 230
-13.8%
|
0,29
|
6 431 USD
|
|
|
2018-11-13 |
2018-11-08 |
VP
Vente planifiée
|
Presnell Sharon Collins
Chief Scientific Officer
Dirigeant
|
40 000
-12.0%
1,27
50 800 USD
|
40 000
-12.0%
|
1,27
|
50 800 USD
|
|
|
2017-12-04 |
2017-11-24 |
A
Achat
|
Murphy Keith
Former affiliate last filing
|
200 500
+3.2%
1,49
299 347 USD
|
200 500
+3.2%
|
1,49
|
299 347 USD
|
|
|
2017-12-04 |
2017-11-22 |
A
Achat
|
Murphy Keith
Former affiliate last filing
|
135 000
+2.2%
1,50
201 960 USD
|
135 000
+2.2%
|
1,50
|
201 960 USD
|
|
|
2017-02-10 |
2017-02-09 |
VP
Vente planifiée
|
Murphy Keith
Chairman, CEO and President
Administrateur exécutif
|
25 000
-0.4%
3,68
92 035 USD
|
25 000
-0.4%
|
3,68
|
92 035 USD
|
|
|
2017-01-25 |
2017-01-24 |
VP
Vente planifiée
|
Murphy Keith
Chairman, CEO and President
Administrateur exécutif
|
20 100
-0.3%
3,50
70 440 USD
|
20 100
-0.3%
|
3,50
|
70 440 USD
|
|
|
2017-01-25 |
2017-01-23 |
VP
Vente planifiée
|
Murphy Keith
Chairman, CEO and President
Administrateur exécutif
|
4 900
-0.1%
3,51
17 215 USD
|
4 900
-0.1%
|
3,51
|
17 215 USD
|
|
|
2016-12-15 |
2016-12-14 |
VP
Vente planifiée
|
Murphy Keith
Chairman, CEO and President
Administrateur exécutif
|
50 000
-0.8%
3,72
185 955 USD
|
50 000
-0.8%
|
3,72
|
185 955 USD
|
|
|
2016-08-09 |
2016-08-05 |
VP
Vente planifiée
|
David Eric
CSO & EVP Pre-Clinical Dev
Dirigeant
|
20 000
-2.8%
4,55
91 000 USD
|
20 000
-2.8%
|
4,55
|
91 000 USD
|
|
|
2015-08-13 |
2015-08-13 |
A
Achat
|
GLOVER JAMES T
Administrateur non-exécutif
|
10 000
+inf%
2,80
28 000 USD
|
10 000
+inf%
|
2,80
|
28 000 USD
|
|
|
2015-08-13 |
2015-08-12 |
A
Achat
|
Murphy Keith
Chairman, CEO and President
Administrateur exécutif
|
20 000
+0.3%
2,56
51 188 USD
|
20 000
+0.3%
|
2,56
|
51 188 USD
|
|
|
2014-12-31 |
2014-12-30 |
VP
Vente planifiée
|
MICHAELS BARRY D
Chief Financial Officer
Dirigeant
|
10 500
-3.5%
7,50
78 771 USD
|
10 500
-3.5%
|
7,50
|
78 771 USD
|
|
|
2014-12-31 |
2014-12-30 |
VP
Vente planifiée
|
David Eric
Chief Strategy Officer
Dirigeant
|
16 300
-2.3%
7,56
123 243 USD
|
16 300
-2.3%
|
7,56
|
123 243 USD
|
|
|
2014-12-31 |
2014-12-29 |
VP
Vente planifiée
|
MICHAELS BARRY D
Chief Financial Officer
Dirigeant
|
4 500
-1.5%
7,50
33 750 USD
|
4 500
-1.5%
|
7,50
|
33 750 USD
|
|
|
2014-02-21 |
2014-02-21 |
VP
Vente planifiée
|
Renard Michael
EVP of Commercial Operations
Dirigeant
|
10 000
-100.0%
10,65
106 500 USD
|
10 000
-100.0%
|
10,65
|
106 500 USD
|
|
|
2014-01-29 |
2014-01-29 |
VP
Vente planifiée
|
Renard Michael
EVP of Commercial Operations
Dirigeant
|
30 000
-100.0%
9,93
297 999 USD
|
30 000
-100.0%
|
9,93
|
297 999 USD
|
|
|
2014-01-29 |
2014-01-27 |
VP
Vente planifiée
|
Renard Michael
EVP of Commercial Operations
Dirigeant
|
10 000
-100.0%
8,92
89 200 USD
|
10 000
-100.0%
|
8,92
|
89 200 USD
|
|
|
2013-11-15 |
2013-11-13 |
V
Vente
|
David Eric
Chief Strategy Officer
Dirigeant
|
16 470
-2.2%
10,39
171 105 USD
|
16 470
-2.2%
|
10,39
|
171 105 USD
|
|
|
2013-10-18 |
2013-10-18 |
VP
Vente planifiée
|
Murphy Keith
Chairman, CEO and President
Administrateur exécutif
|
30 000
-0.5%
6,63
198 990 USD
|
30 000
-0.5%
|
6,63
|
198 990 USD
|
|
|
2013-10-15 |
2013-10-10 |
V
Vente
|
David Eric
Chief Strategy Officer
Dirigeant
|
3 530
-0.5%
5,66
19 996 USD
|
3 530
-0.5%
|
5,66
|
19 996 USD
|
|
